INTRODUCTION Personal Care Products is a term used for a wide range of items typically found in health and beauty departments. Examples can include makeup, perfumes or antiperspirants. The sale of Personal Care Products is at a steady increase with an estimated Compound Annual Growth Rate (CAGR) of 6.5% between 2021-2025. In 2021 alone, revenue is expected to hit $35 million. There is an increasing demand for logistics services to accommodate growth in the personal care industry. Most Person...
Introduction A prominent operator of 90 local cancer clinics throughout Florida required an efficient, expedited logistics solution to deliver medications and therapies to every clinic and coordinate with patient appointments. The complex process involved the return and immediate re-delivery of therapies between facilities. Many products required refrigeration and special handling. WDSrx created a plan to streamline returns and fulfillment with support from Reverse Logistics and Operations teams...
New Projects, Partners and Policies in WDSrx January 2022 News Highlights. The start of the new year brought with it a plethora of new projects for new partners at WDSrx. Take a look at new developments at our company in our News Highlights for January 2022. Diversity & Inclusion WDSrx embraces the legacy and aspirations of the great Dr. Martin Luther King, Jr. everyday by celebrating the diversity and inclusion within our team. To learn how watch our 30 Second video on Diversity &...
The route temperature regulated medications travel from manufacturer to patient is complex, with multiple checks and balances to assure patient safety and therapeutic effectiveness. The Cold Chain Logistics process is a central component ensuring efficiency in the pharmaceutical supply chain. Certain pharmaceutical drug products, such as vaccines and biopharmaceuticals, must be maintained within a consistent temperature range for product potency and patient safety. Temperature Regulated Environm...
Introduction Companies manufacturing pharmaceutical products requiring cold-chain storage at refrigerated or frozen temperatures are facing a scarcity of regulatory-compliant capacity meeting industry standards. The global market for cold chain medications was estimated at $318 billion in 20181 and is expected to rise approximately eight percent annually through 2022. However, the increase in supply for storage, handling and transporting these specialized products is expected to be less than the...